Medicines moved from 12% to 5% on 22 September 2025
The 56th GST Council meeting cut the rate on almost all drugs and medicines from 12% to 5%, effective 22 September 2025. That covers HSN 3003 and 3004, including Ayurvedic, Unani, Siddha and homoeopathic medicines put up for retail sale. Thirty-six specified life-saving drugs, mostly for cancer and rare diseases, became nil-rated. A pharmacy should update the rate on every item master rather than editing bills by hand, because stock bought before the change still carries a 12% printed price but must now be billed at the new rate. Check whether any product you stock is one of the nil-rated molecules.
Bandages, gloves and diagnostic strips are also 5% now
Pharmacies sell more than medicines. Wadding, gauze and bandages (3005), surgical and examination rubber gloves (4015), diagnostic kits and reagents (3822), glucometers and test strips, and medical thermometers (9025) were all brought to 5% in the same round. Toothpaste, toothbrushes, hair oil, shampoo, talcum powder and toilet soap also moved to 5%. Products like perfumes or sunscreen that were not listed in the cut may still sit at 18%, so a counter selling general merchandise needs separate rates per item, not a single store-wide rate.
Composition scheme for small medical stores
A retail pharmacy with turnover up to ₹1.5 crore can opt for the composition scheme and pay a flat 1% on turnover. A composition dealer cannot charge GST on the bill and must issue a bill of supply that says 'composition taxable person, not eligible to collect tax on supplies'. Many pharmacies prefer regular registration because hospitals and clinics buying from them want input tax credit, and because the 5% output rate is now close to the input rate, so credit rarely piles up. Weigh both before switching.
MRP is tax-inclusive, so back-calculate the taxable value
The MRP printed on a strip already includes GST. For a ₹105 MRP item at 5%, the taxable value is ₹100 and GST is ₹5, split as ₹2.50 CGST and ₹2.50 SGST. A common billing error is adding 5% on top of MRP, which overcharges the patient and breaks price-control rules. Your software should take the selling price as inclusive and compute the tax inside it, then show the taxable value per line.
Expired-stock returns and credit notes
When a distributor takes back expired or near-expiry medicines, the correct document depends on who issues it. If the distributor gives you a credit note under section 34, it reduces their output tax and you must reduce your input tax credit. If you instead raise a tax invoice for the return, treat it as a fresh supply. Agree on the method with each distributor and keep the batch numbers on the return document so stock and tax registers stay matched.